PIK3CD and breast neoplasm: Our present results clearly show that the effectiveness of the IC87114 p110δ-selective inhibitor in preventing breast tumour growth and metastasis is not only a result of its efficacy to inhibit the survival and proliferation of cancer cells but also derives from the modulation of macrophage recruitment to tumour sites.